Literature DB >> 22114037

Transcatheter aortic valve replacement in a patient with an anomalous origin of the right coronary artery.

Hellmuth Weich1, Christelle Ackermann, Hofmeyr Viljoen, Jacques van Wyk, Thomas Mabin, Anton F Doubell.   

Abstract

We describe the first case of implantation of a transcatheter aortic valve implantation (TAVI) in a patient with an anomalous origin of the right coronary artery, coursing in between the aorta and pulmonary truncus to the right. After assessment of the risk of compression of the anomalous origin of the right coronary artery from the left coronary sinus (ARCA), the procedure was performed without complication. A brief discussion of the pathophysiology of ARCA is provided and the implications for TAVI as well as our recommendations are offered.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22114037     DOI: 10.1002/ccd.23012

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  4 in total

1.  Aortic Valve Replacement in 8 Adults with Anomalous Aortic Origin of Coronary Artery.

Authors:  Abdallah K Alameddine; Brian J Binnall; Frederick T Conlin; Patrick J Broderick
Journal:  Tex Heart Inst J       Date:  2019-06-01

2.  Transcatheter aortic valve implantation with a balloon-expandable prosthesis in a patient with single coronary artery: a case report.

Authors:  Makoto Furugen; Azusa Furugen; Kenji Yamazaki; Hirosato Doi
Journal:  Eur Heart J Case Rep       Date:  2022-05-03

3.  From the economics of TAVI and the pathophysiology of heart and vessel disease to metabolic disease in Africa and the developing world.

Authors:  Paul A Brink
Journal:  Cardiovasc J Afr       Date:  2014 Jan-Feb       Impact factor: 1.167

Review 4.  Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities.

Authors:  Liesl Zühlke; Mariana Mirabel; Eloi Marijon
Journal:  Heart       Date:  2013-05-16       Impact factor: 5.994

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.